Registered Trials
-
PRO-CL-002, NCT05175742
Phase 2Canada, South Africa
Total Enrollment: 890
Official Trial Registration:
-
PRO-CL-001, NCT04765436
Phase 1Canada
Total Enrollment: 60
Official Trial Registration:
Vaccine Type: RNA
This vaccine has reached Phase 2 trials.
There are no trials for this phase.
This vaccine is not yet approved.
Canada, South Africa
Total Enrollment: 890
Canada
Total Enrollment: 60
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.